{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:06:00Z","timestamp":1792598760523,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,5]],"date-time":"2023-11-05T00:00:00Z","timestamp":1699142400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015539","name":"Australian Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015539","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1136849"],"award-info":[{"award-number":["1136849"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1163961"],"award-info":[{"award-number":["1163961"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1193939"],"award-info":[{"award-number":["1193939"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1195460"],"award-info":[{"award-number":["1195460"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001774","name":"University of Sydney","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001774","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jclinepi.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Epidemiology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.jclinepi.2023.10.020","type":"journal-article","created":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T12:38:14Z","timestamp":1699101494000},"page":"111204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Context matters: using an Evidence to Decision (EtD) framework to develop and encourage uptake of opioid deprescribing guideline recommendations at the point-of-care"],"prefix":"10.1016","volume":"165","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0509-5136","authenticated-orcid":false,"given":"Aili V.","family":"Langford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Bero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Wei Christine","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona M.","family":"Blyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3661-8745","authenticated-orcid":false,"given":"Jason N.","family":"Doctor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8392-9696","authenticated-orcid":false,"given":"Simon","family":"Holliday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2031-9134","authenticated-orcid":false,"given":"Yun-Hee","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4103-7569","authenticated-orcid":false,"given":"Joanna C.","family":"Moullin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridin","family":"Murnion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5341-1055","authenticated-orcid":false,"given":"Suzanne","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Penm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Reeve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5483-8189","authenticated-orcid":false,"given":"Janet","family":"Wale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rawa","family":"Osman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danijela","family":"Gnjidic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2921-5609","authenticated-orcid":false,"given":"Carl R.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jclinepi.2023.10.020_bib1","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/S0140-6736(16)00161-6","article-title":"Use of and barriers to access to opioid analgesics: a worldwide, regional, and national study","volume":"387","author":"Berterame","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jclinepi.2023.10.020_bib2","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1001\/jama.2018.18472","article-title":"Opioids for chronic noncancer pain: a systematic review and meta-analysis","volume":"320","author":"Busse","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jclinepi.2023.10.020_bib3","doi-asserted-by":"crossref","first-page":"276","DOI":"10.7326\/M14-2559","article-title":"The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a national institutes of health pathways to prevention workshop","volume":"162","author":"Chou","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jclinepi.2023.10.020_bib4","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1007\/s11136-018-1941-1","article-title":"Evaluation of opioid use among patients with back disorders and arthritis","volume":"27","author":"Hayes","year":"2018","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jclinepi.2023.10.020_bib5","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1001\/jama.2018.0899","article-title":"Effect of opioid vs nonopioid medications on pain-related function in patients with chronic back pain or hip or knee osteoarthritis pain: the SPACE randomized clinical trial","volume":"319","author":"Krebs","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jclinepi.2023.10.020_bib7","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain--United States, 2016","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jclinepi.2023.10.020_bib8","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/bmjqs-2020-010881","article-title":"Challenges of opioid deprescribing and factors to be considered in the development of opioid deprescribing guidelines: a qualitative analysis","volume":"30","author":"Langford","year":"2020","journal-title":"BMJ Qual Saf"},{"key":"10.1016\/j.jclinepi.2023.10.020_bib9","doi-asserted-by":"crossref","first-page":"80","DOI":"10.5694\/mja2.52002","article-title":"Clinical practice guideline for deprescribing opioid analgesics: summary of recommendations","volume":"219","author":"Langford","year":"2023","journal-title":"Med J Aust"},{"key":"10.1016\/j.jclinepi.2023.10.020_bib10","series-title":"Evidence-based clinical practice guideline for deprescribing opioid analgesics","author":"Langford","year":"2022"},{"key":"10.1016\/j.jclinepi.2023.10.020_bib11","first-page":"230","article-title":"Translating clinical guidelines into practice. Challenges and opportunities in a dynamic health care environment","volume":"76","author":"Vander Schaaf","year":"2015","journal-title":"N C Med J"},{"issue":"6","key":"10.1016\/j.jclinepi.2023.10.020_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta8060","article-title":"Effectiveness and efficiency of guideline dissemination and implementation strategies","volume":"8","author":"Grimshaw","year":"2004","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.jclinepi.2023.10.020_bib13","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jclinepi.2014.12.013","article-title":"Guideline uptake is influenced by six implementability domains for creating and communicating guidelines: a realist review","volume":"68","author":"Kastner","year":"2015","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jclinepi.2023.10.020_bib14","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1097\/j.pain.0000000000002270","article-title":"\"The lesser of two evils\": a framework analysis of consumers' perspectives on opioid deprescribing and the development of opioid deprescribing guidelines","volume":"162","author":"Langford","year":"2021","journal-title":"Pain"},{"key":"10.1016\/j.jclinepi.2023.10.020_bib15","article-title":"GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: introduction","volume":"353","author":"Alonso-Coello","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jclinepi.2023.10.020_bib16","doi-asserted-by":"crossref","first-page":"i2089","DOI":"10.1136\/bmj.i2089","article-title":"GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: clinical practice guidelines","volume":"353","author":"Alonso-Coello","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jclinepi.2023.10.020_bib17","series-title":"Evidence-based Clinical Practice Guideline for Deprescribing Opioid Analgesics \u2013 Administrative Report","author":"Langford","year":"2022"},{"key":"10.1016\/j.jclinepi.2023.10.020_bib18","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/j.pain.0000000000002746","article-title":"Opioid deprescribing in patients with chronic noncancer pain: a systematic review of international guidelines","volume":"164","author":"Hamilton","year":"2023","journal-title":"Pain"},{"key":"10.1016\/j.jclinepi.2023.10.020_bib19","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.pain.2003.08.001","article-title":"Core outcome domains for chronic pain clinical trials: IMMPACT recommendations","volume":"106","author":"Turk","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.jclinepi.2023.10.020_bib20","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/bcpt.13844","article-title":"Patient-targeted interventions for opioid deprescribing: an overview of systematic reviews","volume":"133","author":"Langford","year":"2023","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.jclinepi.2023.10.020_bib21","series-title":"Evidence-based Clinical Practice Guideline for Deprescribing Opioid Analgesics \u2013 Administrative Report","author":"Langford","year":"2022"},{"key":"10.1016\/j.jclinepi.2023.10.020_bib22","article-title":"The GRADE Working Group. GRADE handbook for grading quality of evidence and strength of recommendations","year":"2013"},{"key":"10.1016\/j.jclinepi.2023.10.020_bib24","series-title":"WHO handbook for guideline development, 2nd ed","year":"2014"},{"key":"10.1016\/j.jclinepi.2023.10.020_bib25","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jclinepi.2014.10.011","article-title":"World Health Organization strong recommendations based on low-quality evidence (study quality) are frequent and often inconsistent with GRADE guidance","volume":"72","author":"Alexander","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jclinepi.2023.10.020_bib26","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jclinepi.2013.02.003","article-title":"GRADE guidelines: 15. Going from evidence to recommendation - determinants of a recommendation's direction and strength","volume":"66","author":"Andrews","year":"2013","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jclinepi.2023.10.020_bib27","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/j.pain.0000000000002298","article-title":"Patient outcomes following opioid dose reduction among patients with chronic opioid therapy","volume":"163","author":"Hallvik","year":"2022","journal-title":"Pain"},{"key":"10.1016\/j.jclinepi.2023.10.020_bib28","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jsat.2019.05.001","article-title":"Opioid medication discontinuation and risk of adverse opioid-related health care events","volume":"103","author":"Mark","year":"2019","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.jclinepi.2023.10.020_bib29","series-title":"Communication techniques for opioid analgesic tapering conversations","author":"Langford","year":"2020"},{"key":"10.1016\/j.jclinepi.2023.10.020_bib30","doi-asserted-by":"crossref","first-page":"386","DOI":"10.5694\/mja12.10140","article-title":"Waiting in pain: a systematic investigation into the provision of persistent pain services in Australia","volume":"196","author":"Hogg","year":"2012","journal-title":"Med J Aust"},{"key":"10.1016\/j.jclinepi.2023.10.020_bib31","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1093\/pm\/pnab011","article-title":"Evaluation of the relationship between geographic proximity and treatment for people referred to a metropolitan multidisciplinary pain clinic","volume":"22","author":"Giummarra","year":"2021","journal-title":"Pain Med"},{"key":"10.1016\/j.jclinepi.2023.10.020_bib32","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1177\/1359105317752828","article-title":"Waiting for multidisciplinary chronic pain services: a prospective study over 2.5 years","volume":"25","author":"Burke","year":"2018","journal-title":"J Health Psychol"},{"key":"10.1016\/j.jclinepi.2023.10.020_bib33","series-title":"Opioid harm in Australia: and comparisons between Australia and Canada","year":"2018"},{"key":"10.1016\/j.jclinepi.2023.10.020_bib34","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/bcp.12446","article-title":"An overview of the patterns of prescription opioid use, costs and related harms in Australia","volume":"78","author":"Blanch","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jclinepi.2023.10.020_bib35","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.11997","article-title":"Unintended consequences from the 2016 US Centers for disease Control and prevention guideline for prescribing opioids\u2014accelerating change in postoperative prescribing","volume":"4","author":"Bicket","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jclinepi.2023.10.020_bib36","series-title":"Evidence-based clinical practice guideline for deprescribing opioid analgesics, public consultation summary","author":"Langford","year":"2022"},{"key":"10.1016\/j.jclinepi.2023.10.020_bib37","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jclinepi.2021.09.028","article-title":"A taxonomy and framework for identifying and developing actionable statements in guidelines suggests avoiding informal recommendations","volume":"141","author":"Lotfi","year":"2022","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jclinepi.2023.10.020_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161248","article-title":"Methodology for developing deprescribing guidelines: using evidence and GRADE to guide recommendations for deprescribing","volume":"11","author":"Farrell","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jclinepi.2023.10.020_bib39","series-title":"Developing an evidence-based deprescribing guideline: instruction manual for guideline coordinators (working document)","author":"Thompson","year":"2018"},{"key":"10.1016\/j.jclinepi.2023.10.020_bib40","first-page":"832","article-title":"Deprescribing antihyperglycemic agents in older persons: evidence-based clinical practice guideline","volume":"63","author":"Farrell","year":"2017","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.jclinepi.2023.10.020_bib41","first-page":"339","article-title":"Deprescribing benzodiazepine receptor agonists: evidence-based clinical practice guideline","volume":"64","author":"Pottie","year":"2018","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.jclinepi.2023.10.020_bib42","first-page":"354","article-title":"Deprescribing proton pump inhibitors: evidence-based clinical practice guideline","volume":"63","author":"Farrell","year":"2017","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.jclinepi.2023.10.020_bib43","first-page":"17","article-title":"Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia: evidence-based clinical practice guideline","volume":"64","author":"Bjerre","year":"2018","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.jclinepi.2023.10.020_bib44","series-title":"Evidence-based clinical practice guideline for deprescribing cholinesterase inhibitors and memantine in people with dementia","author":"Reeve","year":"2018"},{"key":"10.1016\/j.jclinepi.2023.10.020_bib45","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13012-018-0763-4","article-title":"The advantages and limitations of guideline adaptation frameworks","volume":"13","author":"Wang","year":"2018","journal-title":"Implement Sci"},{"key":"10.1016\/j.jclinepi.2023.10.020_bib46","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s12940-021-00794-z","article-title":"Evidence-to-decision frameworks: a review and analysis to inform decision-making for environmental health interventions","volume":"20","author":"Norris","year":"2021","journal-title":"Environ Health"},{"key":"10.1016\/j.jclinepi.2023.10.020_bib47","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.sapharm.2018.08.014","article-title":"Deprescribing recommendations: an essential consideration for clinical guideline developers","volume":"15","author":"Moriarty","year":"2019","journal-title":"Res Social Adm Pharm"},{"key":"10.1016\/j.jclinepi.2023.10.020_bib48","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejim.2016.12.021","article-title":"Deprescribing: a narrative review of the evidence and practical recommendations for recognizing opportunities and taking action","volume":"38","author":"Reeve","year":"2017","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jclinepi.2023.10.020_bib49","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1503\/cmaj.190144","article-title":"Guideline groups should make recommendations even if the evidence is considered insufficient","volume":"192","author":"Neumann","year":"2020","journal-title":"CMAJ"},{"key":"10.1016\/j.jclinepi.2023.10.020_bib50","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12955-017-0621-0","article-title":"Using patient values and preferences to inform the importance of health outcomes in practice guideline development following the GRADE approach","volume":"15","author":"Zhang","year":"2017","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.jclinepi.2023.10.020_bib51","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jclinepi.2018.09.007","article-title":"Evidence to Decision framework provides a structured \"roadmap\" for making GRADE guidelines recommendations","volume":"104","author":"Li","year":"2018","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jclinepi.2023.10.020_bib52","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2018-000844","article-title":"The WHO-INTEGRATE evidence to decision framework version 1.0: integrating WHO norms and values and a complexity perspective","volume":"4","author":"Rehfuess","year":"2019","journal-title":"BMJ Glob Health"},{"key":"10.1016\/j.jclinepi.2023.10.020_bib53","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/0021943609340669","article-title":"Cognitive organization and identity maintenance in multicultural teams: a discourse analysis of decision-making meetings","volume":"47","author":"Aritz","year":"2010","journal-title":"J Bus Commun"},{"key":"10.1016\/j.jclinepi.2023.10.020_bib54","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jclinepi.2017.09.023","article-title":"Decision-making frameworks and considerations for informing coverage decisions for healthcare interventions: a critical interpretive synthesis","volume":"94","author":"Morgan","year":"2018","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jclinepi.2023.10.020_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2001221","article-title":"Why having a (nonfinancial) interest is not a conflict of interest","volume":"14","author":"Bero","year":"2016","journal-title":"PLoS Biol"}],"container-title":["Journal of Clinical Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895435623002809?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895435623002809?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T22:06:21Z","timestamp":1745445981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0895435623002809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":53,"alternative-id":["S0895435623002809"],"URL":"https:\/\/doi.org\/10.1016\/j.jclinepi.2023.10.020","relation":{},"ISSN":["0895-4356"],"issn-type":[{"value":"0895-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Context matters: using an Evidence to Decision (EtD) framework to develop and encourage uptake of opioid deprescribing guideline recommendations at the point-of-care","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jclinepi.2023.10.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111204"}}